3B BlackBio Dx Ltd

Director re-appointment

• Re-appointment of Mrs. Mithla Dubey as Director (promoter) approved at AGM on 29 Sep 2026.
• Effective date: 29 September 2026; term of appointment not specified.
• Reason: retire by rotation and eligible for re-appointment per Articles.
• Profile: woman director; promoter; active in social initiatives.
• Relationship: mother of Dhirendra Dubey (Chairman MD) and Nikhil Dubey (WTD CFO).
• Compliance: not debarred from director office per SEBI order.
• Impact: addition of female director to meet minimum women-director requirement.

agm details

• AGM held on 29 September 2026 at 11:30 IST via VC/OAVM.
• Record date for voting and dividend: 22 September 2026.
• Attendance via VC/OAVM: Promoter group 11, Public 42.

resolutions

• Resolution 1: adoption of standalone financial statements for year ended 31 March 2026.
• Resolution 2: adoption of consolidated financial statements for year ended 31 March 2026.
• Resolution 3: dividend of ₹5 per equity share for 2025-26.
• Resolution 4: special resolution for re-appointment of Mithla Dubey by rotation.
• Resolution 5: ordinary resolution to ratify cost auditors' remuneration.

voting results

• Res 1: passed with 99.99% in favour.
• Res 2: passed with 99.99% in favour.
• Res 3: passed with 99.99% in favour.
• Res 4: passed; 96.79% in favour; special resolution.
• Res 5: passed with 99.99% in favour.

dividend

• Dividend proposed/approved: ₹5 per equity share.

directors and auditors

• Director re-appointment: Mithla Dubey by rotation; special resolution.
• Cost Auditors: remuneration ratified; ordinary resolution.

AGM details

• AGM held on 29 September 2026 via VC/OAVM from 11:30 AM to 12:05 PM.
• Quorum present; meeting chaired by CMD.
• Remote e-voting window ran 26–28 September 2026; on-site e-voting during AGM.
• Investor Presentation circulated to members.

Resolutions & voting

• Adopt standalone financial statements for year ended 31 March 2026.
• Adopt consolidated financial statements for year ended 31 March 2026.
• Declare dividend of Rs 5.00 per share on equity shares.
• Re-appoint Mithla Dubey as director, retiring by rotation.
• Ratify remuneration of the cost auditor.
• Voting results to be displayed on company website and submitted to stock exchanges.

3B BlackBio Dx Ltd (Formerly Kilpest India Limited) closes trading window from 1 October 2026 till 48 hours after the unaudited financial results for the quarter and half-year ending 30 September 2026 are announced to the public

Meeting Details

• Date and time: 16 September 2026, 11:00–12:00 IST.
• Type and mode: One-to-one meeting (mode not specified).
• Organizer: Marcellus Investment Managers, Mumbai.
• Key company participant: Whole Time Director.
• Purpose: reiterate Q1-FY27 investor presentation information.
• Materials: Q1-FY27 presentation link shared with investors.

Meeting Details

• Date/time: Wed, Sep 16, 2026 at 11:00 IST.
• Mode: Virtual investor conference call.
• Organizer: Marcellus Investment Managers, Mumbai.
• Type: One-on-One meeting; Single Institution.
• Purpose: Analyst/investor interaction; discuss Q1 FY27 presentation.
• Material: Use of Q1-FY27 investor presentation; hosted on company site.

Meeting Details

• One-to-one investor meeting on 11 September 2026 from 11:00 to 12:00 IST; mode not specified.

Participants

• Key company participant: Whole Time Director.

Purpose

• Reiterated Q1-FY27 investor presentation; discussed publicly available information.

Additional Notes

• Investor presentation for Q1-FY27 is available to investors.
• No unpublished price sensitive information was shared during the meeting.

AGM Details

• 54th AGM on 29 Sep 2026 at 11:30 AM IST via VC/OAVM.

Record Date & Book Closure

• Book closure 23–29 Sep 2026; record date 22 Sep 2026.

Dividend

• Dividend for FY2025-26 payable from 5 Oct 2026.

E-voting Details

• Remote e-voting 26–28 Sep 2026; cut-off 22 Sep 2026.